|
SNUPN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.059570E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.178600E-04 |
| Normal-vs-Stage2 |
1.525830E-01 |
| Normal-vs-Stage3 |
3.377400E-03 |
| Normal-vs-Stage4 |
8.864900E-03 |
| Stage1-vs-Stage2 |
2.098600E-01 |
| Stage1-vs-Stage3 |
8.410400E-01 |
| Stage1-vs-Stage4 |
9.115200E-01 |
| Stage2-vs-Stage3 |
3.358200E-01 |
| Stage2-vs-Stage4 |
3.982600E-01 |
| Stage3-vs-Stage4 |
9.705000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.005890E-04 |
| Normal-vs-AfricanAmerican |
9.915400E-01 |
| Normal-vs-Asian |
3.892800E-01 |
| Caucasian-vs-AfricanAmerican |
5.957800E-03 |
| Caucasian-vs-Asian |
1.344070E-02 |
| AfricanAmerican-vs-Asian |
5.130800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.838760E-03 |
| Normal-vs-Female |
1.696940E-03 |
| Male-vs-Female |
9.907400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.40020000000274E-05 |
| Normal-vs-Age(41-60Yrs) |
1.128220E-02 |
| Normal-vs-Age(61-80Yrs) |
6.136900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.228800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.120500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.328800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.147600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.433200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.030800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.348200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.744200E-02 |
| Classical-VS-Follicular |
8.173000E-01 |
| Classical-VS-Other |
7.984000E-01 |
| Classical-VS-Normal |
2.115800E-03 |
| Tall-VS-Follicular |
3.246000E-02 |
| Tall-VS-Other |
3.718800E-01 |
| Tall-VS-Normal |
6.12569999999257E-05 |
| Follicular-VS-Other |
8.061400E-01 |
| Follicular-VS-Normal |
2.000400E-02 |
| Other-VS-Normal |
5.870000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.169840E-02 |
| Normal-vs-N1 |
2.15859999996848E-06 |
| N0-vs-N1 |
5.842500E-03 |
|
|
